The HemoCue Glucose 201+ System measures glucose levels to diagnose diabetes. The unique microcuvette technology gives high accuracy and reduces contamination risks.
Not available in the US, for corresponding US product,
The HemoCue Glucose 201+ System puts labequivalent answers in health professionals’ hands when they’re needed most — at the point of care. Not only does the unique cuvette technology enable the highest accuracy in just three simple steps, but it reduces serious contamination risks.
Enables right decisions at the point of care
Used for screening, monitoring and diagnosis of diabetes mellitusPrecise monitoring for better glycemic controlReduced risk of missed hypoglycemia in newborns
Reduces margins of error and risks of infection
Microcuvette technology means no need to bring analyzer near patients, reducing the risk of spreading infectionIndividually wrapped microcuvettes to avoid contamination and maximize shelf-lifeNo clinically significant lot-to-lot variation